Skip to main content
. Author manuscript; available in PMC: 2013 Jul 5.
Published in final edited form as: Leuk Lymphoma. 2008 Apr;49(4):690–695. doi: 10.1080/10428190701882146

Table 1.

Patient Characteristics

N=14
Parameter No (Percent) Median (Range)
Diagnosis
MDS 13 (93)
CMML 1(7)
Age (years) 74.5 (58-85)
No. Azacitidine courses 4 (1-10)
IPSS Risk Score 2 (0.5-3)
Bone marrow blasts ≥10% 12 (86)
2 or more cytopenias 10 (72)
Cytogenetics: IPSS Risk category
Low 8 (57)
Intermediate 2 (14)
High 4 (29)
Reason off Azacitidine
No response 7 (59)
Progression 4 (29)
Relapse 2 (14)
Toxicity 1 (7)

Abbreviations: MDS= myelodysplastic syndrome, CMML= chronic myelomonocytic leukemia, IPSS= international prognostic scoring system